Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

Data as of Jan 30
 -0.01 / -1.09%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Revenue and IncomeNet Revenues4.9M1.8M1.1M2.2M
Operating ExpensesGross Income-486.0K-3.0M----
Total Operating Expenses97.9M108.4M99.6M106.8M
Non-Operating ExpensesOperating Income-93.0M-106.5M-98.5M-104.6M
Extraordinary Credit0.
Extraordinary Charge-2.7M-7.6M-9.9M0.00
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-101.8M-116.2M-110.2M-104.1M
Income Taxes-26.0K0.000.000.00
Net Income-101.8M-116.2M-110.2M-104.1M
Shares To Calculate EPSShares To Calculate EPS302.8M340.8M489.7M513.1M
Shares To Calculate EPS Diluted302.8M340.8M489.7M513.1M
Earnings Per ShareEPS-$0.34-$0.34-$0.23-$0.20
EPS Diluted----------

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.